Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
YAP (Yes-associated protein) is a transcription co-activator in the Hippo tumour suppressor pathway and controls cell growth, tissue homeostasis and organ size. YAP is inhibited by the kinase Lats, which phosphorylates YAP to induce its cytoplasmic localization and proteasomal degradation. YAP induces gene expression by binding to the TEAD family transcription factors. Dysregulation of the Hippo-YAP pathway is frequently observed in human cancers. Here we show that cellular energy stress induces YAP phosphorylation, in part due to AMPK-dependent Lats activation, thereby inhibiting YAP activity. Moreover, AMPK directly phosphorylates YAP Ser 94, a residue essential for the interaction with TEAD, thus disrupting the YAP-TEAD interaction. AMPK-induced YAP inhibition can suppress oncogenic transformation of Lats-null cells with high YAP activity. Our study establishes a molecular mechanism and functional significance of AMPK in linking cellular energy status to the Hippo-YAP pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and the direct phosphorylation of YAP on Ser61/94, which is key for the interaction between Yap and Teads (100, 145).”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as [100]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Both glucose starvation (36, 100, 145) and AMPK activators (26, 100, 145) inhibit Yap in different cell types.”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as [100]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Endurance exercise-associated signals linked to YAP/TAZ”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as Mo et al Nature Cell Biol (2015)
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“…the AMPK-DN increased reporter activity, consistent with the notion that AMPK-DN interferes with endogenous AMPK function in a dominant-negative fashion ‥ Metformin, a widely prescribed drug for type II diabetes 35 , activates AMPK, inhibits cell growth and reduces tumor incidence 36, 37 .”
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227
Self-citationRole of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Self-citationZhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
Self-citationTEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Self-citationMetformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
The Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
Cited by
Items 301–400 of 593
Roles of Hippo–YAP/TAZ signalling in intervertebral disc degeneration
Zheng-wei, S., Yuan, T., Chao-shuai, F., Zhu, L., Song, Z., Liu, T.-J., & Hao, D. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114099 · Cited by 26
Targeting Hippo pathway: A novel strategy for Helicobacter pylori-induced gastric cancer treatment
Liu, Y., Zhang, B., Zhou, Y., Xing, Y., Wang, Y., Jia, Y., & Liu, D. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114549 · Cited by 25
STK3/4 Expression Is Regulated in Uterine Endometrial Cells during the Estrous Cycle
Moon, S., Lee, O., Lee, S., Lee, J., Park, H., Park, M., Chang, E. M., Park, K.-H., & Choi, Y. (2019) · Cells · doi:10.3390/cells8121643 · Cited by 25
Self-citationMEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway
Lu, J., Hu, Z., Deng, Y., Wu, Q., Wu, M., & Song, H. X. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100400 · Cited by 25
Apoptosis in Type 2 Diabetes: Can It Be Prevented? Hippo Pathway Prospects
Kilanowska, A., & Ziółkowska, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020636 · Cited by 25
Reciprocal regulation of actin filaments and cellular metabolism
Liu, G., Li, J., & Wu, C. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151281 · Cited by 24
The role of STK11/LKB1 in cancer biology: implications for ovarian tumorigenesis and progression
Kang, J., Gallucci, S., Pan, J., Oakhill, J. S., & Sanij, E. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1449543 · Cited by 24
Metabolic control of progenitor cell propagation during Drosophila tracheal remodeling
Li, Y., Dong, P., Yang, Y., Guo, T., Zhao, Q., Miao, D., Li, H., Lu, T., Xia, F., Lyu, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30492-4 · Cited by 24
AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair
Chen, Z., Wang, C., Jain, A., Srivastava, M., Tang, M., Zhang, H., Feng, X., Nie, L., Su, D., Xiong, Y., et al. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001794 · Cited by 24
Tang, F., & Christofori, G. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1806450 · Cited by 24
The Hippo pathway: Horizons for innovative treatments of peripheral nerve diseases
Feltri, M. L., Weaver, M. R., Belin, S., & Poitelon, Y. (2021) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12431 · Cited by 24
Xiong, J., Dong, X., Li, S., Jiang, F., Chen, J., Yu, S., Dong, B., & Su, Q. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.657378 · Cited by 24
Martín‐Guerrero, S. M., Casado, P., Hijazi, M., Rajeeve, V., Plaza‐Díaz, J., Abadía‐Molina, F., Navascués, J., Cuadros, M. Á., Cutillas, P. R., & Martín‐Oliva, D. (2020) · Biochemical Journal · doi:10.1042/bcj20200525 · Cited by 23
Philippe, C., Pinson, B., Dompierre, J., Pantesco, V., Viollet, B., Daignan‐Fornier, B., & Moenner, M. (2018) · Neoplasia · doi:10.1016/j.neo.2018.03.006 · Cited by 23
Jin, B., Zhu, J., Shi, H., Wen, Z., & Wu, B. (2018) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20187914 · Cited by 23
Hippo signaling in regeneration and aging
Elster, D., & von Eyß, B. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111280 · Cited by 23
Song, Y.-R., Jang, B., Lee, S.-M., Bae, S.-J., Bak, S. B., & Kim, Y. W. (2022) · Molecules · doi:10.3390/molecules27061858 · Cited by 23
Self-citationYAP/TAZ: An epitome of tumorigenesis
Mukherjee, S., Warden, E. A., & Zhang, J. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217806 · Cited by 22
YAP regulates the liver size during the fasting-refeeding transition in mice
Li, X., Fan, S., Cai, C., Gao, Y., Wang, X., Zhang, Y., Liang, H., Li, H., Yang, J., Huang, M., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.12.011 · Cited by 22
Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer
Schiavoni, G., Messina, B., Scalera, S., Memeo, L., Colarossi, C., Mare, M., Blandino, G., Ciliberto, G., Bon, G., & Maugeri‐Saccà, M. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05027-8 · Cited by 22
Deregulation and Therapeutic Potential of the Hippo Pathway in Cancer
Lin, K. C., Park, H. W., & Guan, K. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050202 · Cited by 22
Self-citationRozengurt, E., & Eibl, G. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i15.1797 · Cited by 22
miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression
Fernández-Tussy, P., Cardelo, M. P., Zhang, H., Sun, J., Price, N. L., Boutagy, N. E., Goedeke, L., Cadena-Sandoval, M., Xirouchaki, C. E., Brown, W., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.168476 · Cited by 21
Bioenergetic reprogramming of macrophages reduces drug tolerance in Mycobacterium tuberculosis
Yadav, V., Sahoo, S., Malhotra, N., Mishra, R., Sreedharan, S., Rajmani, R. S., Shanmugam, S. K., Shandil, R. K., Narayanan, S., Thacker, V. V., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64407-w · Cited by 22
The Hippo pathway and its correlation with acute kidney injury
Zhang, C., 上海交通大学附属第一人民医院肾内科, 上. 2., Li, C., Xu, K., Zheng, Z., Cheng, G., Wu, H., Liu, J., & 复旦大学基础医学院病理科, 上. 2. (2022) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2022.110 · Cited by 21
Fu, R., Guo, X., Pan, Z., Wang, Y., Xu, J., Zhang, L., & Li, J. (2023) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-023-04200-x · Cited by 21
HnRNPR-mediated UPF3B mRNA splicing drives hepatocellular carcinoma metastasis
Wang, H., Qian, D., Wang, J., Liu, Y., Luo, W., Zhang, H., Cheng, J., Li, H., Wu, Y., Li, W., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.02.010 · Cited by 21
Cui, H., Han, W., Zhang, J., Zhang, Z., & Su, X. (2019) · Journal of Cancer · doi:10.7150/jca.31359 · Cited by 21
Becker, H., Renner, S., Technau, G. M., & Berger, C. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005961 · Cited by 21
Patel, N., Nassal, D. M., Gratz, D. H., & Hund, T. J. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1849145 · Cited by 20
Kim, C.-L., Shin, Y.-S., Choi, S.-H., Oh, S., Kim, K., Jeong, H.-S., & Mo, J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5619761 · Cited by 20
Self-citationCellular feedback dynamics and multilevel regulation driven by the hippo pathway
Park, J., & Hansen, C. G. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200253 · Cited by 20
Self-citationAMPK stimulation inhibits YAP/TAZ signaling to ameliorate hepatic fibrosis
Shihan, M. H., Sharma, S. K., Cable, C., Prathigudupu, V., Chen, A. J., Mattis, A. N., & Chen, J. Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-55764-5 · Cited by 19
The Hippo Pathway in Innate Anti-microbial Immunity and Anti-tumor Immunity
Zhang, Q., Zhou, R., & Xu, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01473 · Cited by 19
LDL receptor‐related protein LRP6 senses nutrient levels and regulates Hippo signaling
Jeong, W., Kim, S.-Y., Lee, U., Zhong, Z. A., Savitsky, M., Kwon, H., Kim, J.-Y., Lee, T. B., Cho, J. W., Williams, B. O., et al. (2020) · EMBO Reports · doi:10.15252/embr.202050103 · Cited by 19
Self-citationZhao, D., Xia, L., Geng, W., Xu, D., Zhong, C., Zhang, J., & Xia, Q. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15674 · Cited by 19
Guo, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.862791 · Cited by 19
Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets
Porazinski, S. R., & Ladomery, M. (2018) · Genes · doi:10.3390/genes9030161 · Cited by 19
Targeting YAP/TAZ–TEAD and their protein-protein interaction for precision cancer therapy
Chen, F., Su, J., Liu, Y., Zhang, Z., Li, S., Yuan, Y., & Lai, J. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118330 · Cited by 18
Yang, C., Rubin, L., Yu, X., Lazarovici, P., & Zheng, W. (2024) · Medicinal Research Reviews · doi:10.1002/med.22014 · Cited by 18
The hippo pathway: a molecular bridge between environmental cues and pace of life
Ahi, E. P., Panda, B., & Primmer, C. R. (2025) · BMC Ecology and Evolution · doi:10.1186/s12862-025-02378-8 · Cited by 18
Glucose activates the primordial follicle through the AMPK/mTOR signaling pathway
Xu, S., Wu, X., Dong, Y., Xu, M., Li, Z., Chen, S., Zhuo, Y., Lin, Y., Che, L., Fang, Z., et al. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.122 · Cited by 18
Metformin and LW6 impairs pancreatic cancer cells and reduces nuclear localization of YAP1
Zhang, X., Liu, P., Shang, Y., Kerndl, H., Kumstel, S., Gong, P., Vollmar, B., & Zechner, D. (2019) · Journal of Cancer · doi:10.7150/jca.33029 · Cited by 18
Feliciano, D., Ott, C. M., Espinosa-Medina, I., Weigel, A. V., Benedetti, L., Milano, K. M., Tang, Z., Lee, T., Kliman, H. J., Guller, S. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24708-2 · Cited by 17
Regulation of AMPK activation by extracellular matrix stiffness in pancreatic cancer
Xu, X., Fang, Y., Nowsheen, S., Li, Y., Lou, Z., & Deng, M. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.05.022 · Cited by 17
An, Y., Tan, S., Yang, J., Gao, T., & Dong, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1344697 · Cited by 17
Direct Inhibition of the YAP : TEAD Interaction: An Unprecedented Drug Discovery Challenge
Chêne, P. (2024) · ChemMedChem · doi:10.1002/cmdc.202400361 · Cited by 17
The Emerging Link between the Hippo Pathway and Non-coding RNA
Shimoda, M., & Moroishi, T. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00795 · Cited by 17
The LKB1–TSSK1B axis controls YAP phosphorylation to regulate the Hippo–YAP pathway
Kim, C.-L., Lim, S.-B., Choi, S.-H., Kim, D. H., Sim, Y. E., Jo, E.-H., Kim, K., Lee, K., Park, H.-S., Lim, S. B., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06465-4 · Cited by 16
Self-citationLiu, Y., Yang, Z., Na, J., Chen, X., Wang, Z., Zheng, L., & Fan, Y. (2025) · The FASEB Journal · doi:10.1096/fj.202402944r · Cited by 16
Advances in Understanding the LncRNA-Mediated Regulation of the Hippo Pathway in Cancer
Wang, M., Xu, T., Feng, W.-Y., Liu, J., & Wang, Z. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s283157 · Cited by 16
Wang, H., Xu, P. A., Luo, X., Hu, M., Liu, Y., Yang, Y., Peng, W., Bai, Y., Chen, X., Tan, B., et al. (2020) · Biology of Reproduction · doi:10.1093/biolre/ioaa112 · Cited by 15
Qiu, H., Zhang, X., Qi, J., Zhang, J., Tong, Y., Li, L., Fu, L., Qin, Y., Guan, X., & Zhang, L.-Y. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02435-w · Cited by 15
Inhibition of EZH2 exerts antitumorigenic effects in renal cell carcinoma via LATS1
Hong, S. H., Hwang, H. J., Son, D. H., Kim, E. S., Park, S. Y., & Yoon, Y. E. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13579 · Cited by 15
Kang, L., Yi, J., Lau, C., He, L., Chen, Q., Xu, S., Li, J., Xia, Y. Y., Zhang, Y., Huang, Y., et al. (2023) · Antioxidants · doi:10.3390/antiox12091681 · Cited by 15
The hippo pathway provides novel insights into lung cancer and mesothelioma treatment
Liu, X., Zuo, R. M., & Ou, W. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2727-0 · Cited by 15
Viral Manipulation of a Mechanoresponsive Signaling Axis Disassembles Processing Bodies
Castle, E. L., Robinson, C.-A., Douglas, P., Rinker, K. D., & Corcoran, J. A. (2021) · Molecular and Cellular Biology · doi:10.1128/mcb.00399-21 · Cited by 15
Himes, B. E., Obraztsova, K., Lian, L., Shumyatcher, M., Rue, R. W., Atochina‐Vasserman, E. N., Hur, S. K., Bartolomei, M. S., Evans, J. F., & Krymskaya, V. P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197105 · Cited by 15
Hao, S., Matsui, Y., Lai, Z.-C., & Paulson, R. F. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.11.002 · Cited by 14
The Hippo pathway: an emerging role in urologic cancers.
Cinar, B., Alp, E., Al‐Mathkour, M. M., Boston, A. M., Dwead, A. M., Khazaw, K., & Gregory, A. (2021) · American Journal of Clinical and Experimental Urology · Cited by 14
Xu, T., Wei, D., Yang, Z., Xie, S., Yan, Z., Chen, C., Hu, W., Shi, Z., Zhao, Y., Cui, M., et al. (2023) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2023.109642 · Cited by 14
Hippo pathway in intestinal diseases: focusing on ferroptosis
Deng, H., Jia, Q., Ming, X., Sun, Y., Lu, Y., Liu, L., & Zhou, J. F. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1291686 · Cited by 14
Research progress of the Hippo signaling pathway in renal cell carcinoma
Yang, Y., Gan, X., Zhang, W., Zhu, B., Huangfu, Z., Shi, X., & Wang, L. (2024) · Asian journal of urology · doi:10.1016/j.ajur.2024.02.005 · Cited by 14
The LINC Complex Assists the Nuclear Import of Mechanosensitive Transcriptional Regulators
Takata, T., & Matsumura, M. (2022) · Results and problems in cell differentiation · doi:10.1007/978-3-031-06573-6_11 · Cited by 13
Knockdown of hepatic mitochondrial calcium uniporter mitigates MASH and fibrosis in mice
Li, S., Chen, F., Liu, M., Zhang, Y., Xu, J., Li, X., Shang, Z., Huang, S., Song, S., & Tu, C. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01315-4 · Cited by 13
D-ribose-5-phosphate inactivates YAP and functions as a metabolic checkpoint
Tu, C., Liu, Y., Liu, H.-W., Jiao, C.-M., Liu, Q., Hung, M., Li, P., Wan, X., Fan, X.-J., & Wang, Y. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01655-1 · Cited by 13
Ziegler, N., Bader, E., Epanchintsev, A., Margerie, D., Kannt, A., & Schmoll, D. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013990 · Cited by 13
Clinical potential of the Hippo-YAP pathway in bladder cancer
Cheng, X., Lou, K., Ding, L., Zou, X., Huang, R., Xu, G., Zou, J., & Zhang, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.925278 · Cited by 13
Zhang, W., Li, Q., Gao, H., Wang, Y., Cheng, M., & Wang, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.925254 · Cited by 13
Ippolito, F., Consalvi, V., Noce, V., Battistelli, C., Cicchini, C., Tripodi, M., Amicone, L., & Marchetti, A. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05569-7 · Cited by 13
The Hippo pathway in endometrial cancer: a potential therapeutic target?
Shen, X., Li, Q., Sun, Y., Chen, L., Xue, F., Tian, W., & Wang, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1273345 · Cited by 13
Hippo and PI5P4K signaling intersect to control the transcriptional activation of YAP
Palamiuc, L., Johnson, J. L., Haratipour, Z., Loughran, R. M., Choi, W. J., Arora, G. K., Tieu, V., Ly, K., Lope, A. L., Crabtree, S., et al. (2024) · Science Signaling · doi:10.1126/scisignal.ado6266 · Cited by 13
Energy stress tames the Hippo pathway
Hariharan, I. K. (2015) · Nature Cell Biology · doi:10.1038/ncb3141 · Cited by 14
The Hippo pathway: a renewed insight in the craniofacial diseases and hard tissue remodeling
Chen, J., Cheng, J., Zhao, C., Zhao, B., Mi, J., & Li, W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.63305 · Cited by 13
Zeng, F., Zhou, M., Li, Q., Hu, H., & Chen, C. (2024) · NeuroToxicology · doi:10.1016/j.neuro.2024.08.001 · Cited by 12
ALDOA contributes to colorectal tumorigenesis and metastasis by targeting YAP
Sun, L., Lü, T., Jiang, L., Yao, H., Xu, Q., Sun, J., Yang, X., He, S., & Zhu, X. (2025) · Cell Death Discovery · doi:10.1038/s41420-024-02249-z · Cited by 12
Engineering stem cell metabolism using biomaterial-induced mechanotransduction
Verbakel, J., & de Boer, J. (2025) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100192 · Cited by 12
Scalable and multiplexed recorders of gene regulation dynamics across weeks
Zheng, L., Shi, D., Yan, Y., Zhou, B., Lim, J., Hou, Y., An, B., Adhinarta, J. K., Lin, M., Ko, B., et al. (2026) · Nature · doi:10.1038/s41586-026-10156-9 · Cited by 13
O-GlcNAcylation: An Emerging Protein Modification Regulating the Hippo Pathway
Kim, E., Kang, J. G., Jho, E., Yang, W. H., & Cho, J. W. (2022) · Cancers · doi:10.3390/cancers14123013 · Cited by 12
Liu, X., Guo, H., Long, G., Ma, Y., Gong, L., Zhang, M., Hull, J. J., Dewer, Y., Liu, L., He, M., et al. (2023) · Pest Management Science · doi:10.1002/ps.7464 · Cited by 12
Yang, T., Yuan, J., Peng, Y., Pang, J., Qiu, Z. D., Chen, S., Huang, Y., Jiang, Z., Fan, Y., Liu, J., et al. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.08.012 · Cited by 12
YAP promotes global mRNA translation to fuel oncogenic growth despite starvation
Hwang, D., Baek, S., Chang, J., Seol, T., Ku, B., Ha, H., Lee, H., Cho, S., Roh, T., Kim, Y. K., et al. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01316-w · Cited by 12
Self-citationYang, J.-H., Choi, H.-P., Yang, A., Azad, R., Chen, F., Liu, Z., & Azadzoi, K. M. (2021) · Cells · doi:10.3390/cells10051031 · Cited by 12
YAP Expression and Activity Are Suppressed by S100A7 via p65/NFκB-mediated Repression of ΔNp63
Li, Y., Kong, F., Shao, Q., Wang, R., Hu, E.-Z., Liu, J., Jin, C., He, D., & Xiao, X. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0349 · Cited by 12
Tang, W., Yang, Y., Fu, Z., Xu, W., Ou, W., Liu, F., Du, P., & Liu, C. (2024) · Oncogene · doi:10.1038/s41388-024-03160-8 · Cited by 11
Versatile roles of disordered transcription factor effector domains in transcriptional regulation
Datta, R. R., Akdogan, D., Tezcan, E. B., & Önal, P. (2025) · FEBS Journal · doi:10.1111/febs.17424 · Cited by 11
Neogenin suppresses tumor progression and metastasis via inhibiting Merlin/YAP signaling
Hu, X., Li, L., Li, F., Yang, Y., An, J., Zhou, X., Zhang, R., Shi, L.-L., Zhao, H., Wang, J., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01345-w · Cited by 11
Clinical significance of AJUBA, YAP1, and MMP14 expression in esophageal squamous cell carcinoma.
Zhang, Q., Lou, L., Cai, X., Hao, Z., Nie, S., Liu, Y., Su, L., Wu, W., Shen, H., & Li, Y. (2018) · Europe PMC (PubMed Central) · Cited by 11
Control of myeloid cell density in barrier tissues
Lohrmann, F., Forde, A. J., Merck, P., & Henneke, P. (2020) · FEBS Journal · doi:10.1111/febs.15436 · Cited by 11
Genome-wide RNA interference screening reveals a COPI-MAP2K3 pathway required for YAP regulation
Kim, Y. J., Jung, E., Shin, E., Hong, S., Jeong, H. S., Hur, G., Jeong, H. Y., Lee, S., Lee, J. E., Kim, G., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1915387117 · Cited by 11
Self-citationObesity Potentiates Esophageal Squamous Cell Carcinoma Growth and Invasion by AMPK‐YAP Pathway
Liu, J., Wu, Q., Fu, J., Che, X., & Li, H.-J. (2020) · Journal of Immunology Research · doi:10.1155/2020/6765474 · Cited by 11
LncRNA coordinates Hippo and mTORC1 pathway activation in cancer
Zhang, S., Liang, S., Wu, D., Guo, H., Ma, K., & Liu, L. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04112-w · Cited by 11
Phosphorylation analysis of the Hippo-YAP pathway using Phos-tag
Kim, C.-L., Lim, S., Kim, K., Jeong, H.-S., & Mo, J. (2022) · Journal of Proteomics · doi:10.1016/j.jprot.2022.104582 · Cited by 11
Self-citationPhase separation in immune regulation and immune-related diseases
Huang, N., Dong, H., & Shao, B. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02253-9 · Cited by 11
Ando, T., Okamoto, K., Shintani, T., Yanamoto, S., Miyauchi, M., Gutkind, J. S., & Kajiya, M. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12101544 · Cited by 11
KIBRA connects Hippo signaling and cancer
Srikanth Swamy Swaroop, B., Kanumuri, R., Ezhil, I., Sampangi, J. K. N., Kremerskothen, J., Rayala, S. K., & Venkatraman, G. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112613 · Cited by 11
TEAD activity is restrained by MYC and stratifies human breast cancer subtypes
Elster, D., Jaenicke, L. A., Eilers, M., & von Eyß, B. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1207837 · Cited by 11
The role of (pro)renin receptor and its soluble form in cardiovascular diseases
Wang, B., Jie, H., Wang, S., Dong, B., & Zou, Y. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1086603 · Cited by 10
Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy
Zhu, J., Wu, T., & Lin, Q. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08329-0 · Cited by 10
Qiao, Y., Xia, Q., Cao, X., Xu, J., Qiao, Z., Wu, L., Chen, Z., Yang, L., & Lu, X. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03043-5 · Cited by 10
Metadata
- Authors
- Mo, J.-S., Meng, Z., Kim, Y. C., Park, H. W., Hansen, C. G., Kim, S., Lim, D.-S., & Guan, K.-L.
- Affiliations
- University of California San Diego (US)
- Veterans Medical Research Foundation of San Diego (US)
- Korea Advanced Institute of Science and Technology (KR)
- Corresponding author
- Guan, Kun-Liang
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2015-03-09
- Volume
- 17
- Issue
- 4
- Pages
- 500-510
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC4380774
- OpenAlex
- W1999661963
- Cited by
- 557
- References
- 51
- Citations by year
- 2026: 39 · 2025: 42 · 2024: 54 · 2023: 54 · 2022: 55 · 2021: 48 · 2020: 72 · 2019: 43 · 2018: 53 · 2017: 39 · 2016: 38 · 2015: 20
- FWCI
- 26.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Eye Institute (R01EY022611, EY022611)
- National Cancer Institute (CA 23100, CA132809, R01CA132809, P30CA023100)
- National Institute of Dental and Craniofacial Research (DE015964, R01DE015964)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- YAP, Hippo signaling pathway, AMPK, LATS kinase, YAP phosphorylation, TEAD transcription factors, oncogenic transformation, tumor suppression, glucose homeostasis, starvation
- MeSH terms
- Hippo Signaling Pathway, YAP-Signaling Proteins, TEA Domain Transcription Factors, Acyltransferases, Animals, Cell Line, Cell Transformation, Neoplastic, Cytoplasm, DNA-Binding Proteins, Energy Metabolism, Enzyme Activation, HeLa Cells, Humans, Mice, Nude, Nuclear Proteins, Phosphoproteins, Phosphorylation, Transcription Factors, Signal Transduction, 3T3 Cells, Protein Serine-Threonine Kinases, RNA Interference, RNA, Small Interfering, Adaptor Proteins, Signal Transducing, Mice, AMP-Activated Protein Kinases, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.